Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New EGFR/HER2 kinase inhibitors under study at Wyeth

July 8, 2003

Approval sought for Plenaxis in Germany

July 7, 2003

Phase I trial initiated for MLN-944

July 7, 2003

SAHA enters phase I trial in advanced leukemias

July 7, 2003

New Src/MEK kinase inhibitors in early development at AstraZeneca

July 7, 2003

Endovion shows promising results in preclinical and phase I studies

July 4, 2003

Trials confirm the efficacy and safety of bortezomib in multiple myeloma and mantle cell lymphoma

July 4, 2003

Genmab files CTA to begin phase I/II trial of HuMax-EGFr

July 4, 2003

Genasense receives fast track designation in CLL

July 4, 2003

Fast track designation awarded to Avastin

July 4, 2003

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...